Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure

Journal of Cardiac Failure

Volumn 11, Issue 1, 2005, Pages 50-55

  Watanabe, Jun ^a   Shiba, Nobuyuki ^a   Shinozaki, Tsuyoshi ^a   Koseki, Yoshito ^a   Karibe, Akihiko ^a   Komaru, Tatsuya ^a   Miura, Masahito ^a   Fukuchi, Mitsumasa ^a   Fukahori, Kouhei ^a   Sakuma, Masahito ^a   Kagaya, Yutaka ^a   Shirato, Kunio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain natriuretic peptide; Chronic heart failure; Left ventricular dimensions; Sudden death

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL MODEL; SUDDEN DEATH;

EID: 20844445094     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.06.434     Document Type: Article

References (23)

1. T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, Y. Maeda, and D. Fukai Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
2. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, and M. Jougasaki Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
3. Y. Koseki, J. Watanabe, T. Shinozaki, M. Sakuma, T. Komaru, and M. Fukuchi The CHART Investigators Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan Circ J 67 2003 431 436
4. R. Berger, M. Huelsman, K. Strecker, A. Bojic, P. Moser, and B. Stanek B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
5. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
6. H.V. Huikuri, A. Castellanos, and R.J. Myerburg Sudden death due to cardiac arrhythmias N Engl J Med 345 2001 1473 1482
7. P. Ponikowski, S.D. Anker, T.P. Chua, R. Szelemej, M. Piepoli, and S. Adamopoulos Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 79 1997 1645 1650
8. C.S. Barr, A. Naas, M. Freeman, C.C. Lang, and A.D. Struthers QT dispersion and sudden unexpected death in chronic heart failure Lancet 343 1994 327 329
9. J. Koyama, J. Watanabe, A. Yamada, Y. Koseki, Y. Konno, and S. Toda Evaluation of heart-rate turbulence as a new prognostic marker in patients with chronic heart failure Circ J 66 2002 902 907
10. K. Adachi, Y. Ohnishi, T. Shima, K. Yamashiro, A. Takei, and N. Tamura Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy J Am Coll Cardiol 34 1999 374 380
11. A.M. Richards, M.G. Nicholls, E.A. Espiner, J.G. Lainchbury, R.W. Troughton, and J. Elliott B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 107 2003 2786 2792
12. K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1993 107 115
13. S.A. Hunt, D.W. Baker, M.H. Chin, M.P. Cinquegrani, A.M. Feldman, and G.S. Francis ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 38 2001 2101 2113
14. H. Tsutsui, M. Tsuchihashi, and A. Takeshita Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function Am J Cardiol 88 2001 530 533
15. P. Varadarajan, and R.G. Pai Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients J Card Fail 9 2003 107 112
16. H.H. Chen, and J.C. Burnett Natriuretic peptides in the pathophysiology of congestive heart failure Curr Cardiol Rep 2 2000 198 205
17. H. Tokola, N. Hautala, M. Marttila, J. Magga, S. Pikkarainen, and R. Kerkela Mechanical load-induced alterations in B-type natriuretic peptide gene expression Can J Physiol Pharmacol 79 2001 646 653
18. Y. Wakayama, M. Miura, Y. Sugai, Y. Kagaya, J. Watanabe, and H.E. ter Keurs Stretch and quick release of rat cardiac trabeculae accelerates Ca2+ waves and triggered propagated contractions Am J Physiol Heart Circ Physiol 281 2001 H2133 H2142
19. W.G. Stevenson, and M.O. Sweeney Arrhythmias and sudden death in heart failure Jpn Circ J 61 1997 727 740
20. The CAPRICORN Investigators Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
21. J.N. Cohn, G. Tognoni, and for the Valsartan Heart Failure Trial Investigators A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure New Engl J Med 345 2001 1667 1675
22. P.A. Poole-Wilson, K. Swedberg, J.G.F. Cleland, A. Di Lenarda, P. Hanrath, and M. Komajda for the COMET investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 12
23. I.S. Anand, L.D. Fisher, Y.T. Chiang, R. Latini, S. Masson, and A.P. Maggioni Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 2003 1231 1233